ClearPoint Neuro, Inc. Derivative Liability
ClearPoint Neuro, Inc. (CLPT) had Derivative Liability of -$164.26 thousand as of 2016-12-31, per its 10-K filed 2018-03-21.
Discontinued › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2018-03-21
- 2016-12-31: Derivative Liability -$164.26K.
- 2013-09-30: Derivative Liability $4.11M.
- 2013-06-30: Derivative Liability $2.86M.
- 2013-03-31: Derivative Liability $3.81M.
| Period end | Derivative Liability |
|---|---|
| 2016-12-31 | -$164.26K 10-K · filed 2018-03-21 |
| 2013-09-30 | $4.11M 10-Q · filed 2013-11-13 |
| 2013-06-30 | $2.86M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $3.81M 10-Q/A · filed 2013-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |